The global market for Medical Nuclide Products was valued at US$ 9552 million in the year 2024 and is projected to reach a revised size of US$ 18936 million by 2031, growing at a CAGR of 9.2% during the forecast period.

Medical Nuclide Products Market

Medical nuclide products refer to medical preparations or devices containing radioactive isotopes, which achieve diagnostic or therapeutic functions through the radiation released by their decay. Such products must strictly comply with radioactive safety standards and are widely used in the field of nuclear medicine. For example, imaging agents used in diagnosis assist in disease detection through gamma-ray imaging, and iodine-131 and lutetium-177 used in treatment destroy diseased tissues through targeted radiation. Their production, quality control and clinical use are subject to the dual constraints of national nuclear safety regulations and the drug regulatory system to ensure patient safety and the effectiveness of diagnosis and treatment.

The global medical nuclide products market is being driven by the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurodegenerative conditions, which require precise diagnostic imaging and targeted radiopharmaceutical therapies. Technological advancements in nuclear imaging modalities like PET and SPECT, combined with the increasing adoption of theranostic approaches, have significantly expanded clinical applications for medical nuclides. In addition, favorable government initiatives to promote nuclear medicine infrastructure, and increasing investment in radioisotope production facilities, particularly in developing regions, are further accelerating market growth.

Despite its potential, the medical nuclide products market faces several challenges. The short half-life of many radioisotopes requires localized and timely production, which puts pressure on logistics and supply chain networks, especially in geographically dispersed regions. Regulatory complexities surrounding the handling, transport, and storage of radioactive materials also increase operational burden. Moreover, a global shortage of key isotopes like Mo-99, and limited access to cyclotrons and nuclear reactors in many countries, hampers consistent supply. High costs and the scarcity of trained nuclear medicine professionals further constrain market expansion in certain areas.

This report aims to provide a comprehensive presentation of the global market for Medical Nuclide Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Nuclide Products.

The Medical Nuclide Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Medical Nuclide Products market comprehensively. Regional market sizes, concerning products by Type, by Application, by Product and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medical Nuclide Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Medical Nuclide Products Market Report

Report Metric	Details
Report Name	Medical Nuclide Products Market
Accounted market size in year	US$ 9552 million
Forecasted market size in 2031	US$ 18936 million
CAGR	9.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Technetium-99m Fluorine-18 Gallium-68 Iodine-123 Indium-111 Copper-64 Xenon-133 Iodine-131 Yttrium-90 Lutetium-177 Strontium-89 Samarium-153 Radium-223 Iodine-125 Other
Segment by Product	Therapeutic Nuclear Medicine Diagnostic Nuclear Medicine
Segment by Application	Cancer Cardiovascular Disease Bone and Joint Disease Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Saide Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Product etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Nuclide Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Medical Nuclide Products Market growing?

Ans: The Medical Nuclide Products Market witnessing a CAGR of 9.2% during the forecast period 2025-2031.

What is the Medical Nuclide Products Market size in 2031?

Ans: The Medical Nuclide Products Market size in 2031 will be US$ 18936 million.

Who are the main players in the Medical Nuclide Products Market report?

Ans: The main players in the Medical Nuclide Products Market are Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Yantai Dongcheng Pharmaceutical, Saide Biotechnology

What are the Application segmentation covered in the Medical Nuclide Products Market report?

Ans: The Applications covered in the Medical Nuclide Products Market report are Cancer, Cardiovascular Disease, Bone and Joint Disease, Other

What are the Type segmentation covered in the Medical Nuclide Products Market report?

Ans: The Types covered in the Medical Nuclide Products Market report are Technetium-99m, Fluorine-18, Gallium-68, Iodine-123, Indium-111, Copper-64, Xenon-133, Iodine-131, Yttrium-90, Lutetium-177, Strontium-89, Samarium-153, Radium-223, Iodine-125, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Medical Nuclide Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Technetium-99m

1.2.3 Fluorine-18

1.2.4 Gallium-68

1.2.5 Iodine-123

1.2.6 Indium-111

1.2.7 Copper-64

1.2.8 Xenon-133

1.2.9 Iodine-131

1.2.10 Yttrium-90

1.3 Market by Product

1.3.1 Global Medical Nuclide Products Market Size Growth Rate by Product: 2020 VS 2024 VS 2031

1.3.2 Therapeutic Nuclear Medicine

1.3.3 Diagnostic Nuclear Medicine

1.4 Market by Application

1.4.1 Global Medical Nuclide Products Market Growth by Application: 2020 VS 2024 VS 2031

1.4.2 Cancer

1.4.3 Cardiovascular Disease

1.4.4 Bone and Joint Disease

1.4.5 Other

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Global Medical Nuclide Products Market Perspective (2020-2031)

2.2 Global Medical Nuclide Products Growth Trends by Region

2.2.1 Global Medical Nuclide Products Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Medical Nuclide Products Historic Market Size by Region (2020-2025)

2.2.3 Medical Nuclide Products Forecasted Market Size by Region (2026-2031)

2.3 Medical Nuclide Products Market Dynamics

2.3.1 Medical Nuclide Products Industry Trends

2.3.2 Medical Nuclide Products Market Drivers

2.3.3 Medical Nuclide Products Market Challenges

2.3.4 Medical Nuclide Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Medical Nuclide Products Players by Revenue

3.1.1 Global Top Medical Nuclide Products Players by Revenue (2020-2025)

3.1.2 Global Medical Nuclide Products Revenue Market Share by Players (2020-2025)

3.2 Global Top Medical Nuclide Products Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Medical Nuclide Products Revenue

3.4 Global Medical Nuclide Products Market Concentration Ratio

3.4.1 Global Medical Nuclide Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Medical Nuclide Products Revenue in 2024

3.5 Global Key Players of Medical Nuclide Products Head office and Area Served

3.6 Global Key Players of Medical Nuclide Products, Product and Application

3.7 Global Key Players of Medical Nuclide Products, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Medical Nuclide Products Breakdown Data by Type

4.1 Global Medical Nuclide Products Historic Market Size by Type (2020-2025)

4.2 Global Medical Nuclide Products Forecasted Market Size by Type (2026-2031)

5 Medical Nuclide Products Breakdown Data by Application

5.1 Global Medical Nuclide Products Historic Market Size by Application (2020-2025)

5.2 Global Medical Nuclide Products Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Medical Nuclide Products Market Size (2020-2031)

6.2 North America Medical Nuclide Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Medical Nuclide Products Market Size by Country (2020-2025)

6.4 North America Medical Nuclide Products Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Medical Nuclide Products Market Size (2020-2031)

7.2 Europe Medical Nuclide Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Medical Nuclide Products Market Size by Country (2020-2025)

7.4 Europe Medical Nuclide Products Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Medical Nuclide Products Market Size (2020-2031)

8.2 Asia-Pacific Medical Nuclide Products Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Medical Nuclide Products Market Size by Region (2020-2025)

8.4 Asia-Pacific Medical Nuclide Products Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Medical Nuclide Products Market Size (2020-2031)

9.2 Latin America Medical Nuclide Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Medical Nuclide Products Market Size by Country (2020-2025)

9.4 Latin America Medical Nuclide Products Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Medical Nuclide Products Market Size (2020-2031)

10.2 Middle East & Africa Medical Nuclide Products Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Medical Nuclide Products Market Size by Country (2020-2025)

10.4 Middle East & Africa Medical Nuclide Products Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Cardinal Health

11.1.1 Cardinal Health Company Details

11.1.2 Cardinal Health Business Overview

11.1.3 Cardinal Health Medical Nuclide Products Introduction

11.1.4 Cardinal Health Revenue in Medical Nuclide Products Business (2020-2025)

11.1.5 Cardinal Health Recent Development

11.2 GE Healthcare

11.2.1 GE Healthcare Company Details

11.2.2 GE Healthcare Business Overview

11.2.3 GE Healthcare Medical Nuclide Products Introduction

11.2.4 GE Healthcare Revenue in Medical Nuclide Products Business (2020-2025)

11.2.5 GE Healthcare Recent Development

11.3 Lantheus Medical Imaging

11.3.1 Lantheus Medical Imaging Company Details

11.3.2 Lantheus Medical Imaging Business Overview

11.3.3 Lantheus Medical Imaging Medical Nuclide Products Introduction

11.3.4 Lantheus Medical Imaging Revenue in Medical Nuclide Products Business (2020-2025)

11.3.5 Lantheus Medical Imaging Recent Development

11.4 Bayer

11.4.1 Bayer Company Details

11.4.2 Bayer Business Overview

11.4.3 Bayer Medical Nuclide Products Introduction

11.4.4 Bayer Revenue in Medical Nuclide Products Business (2020-2025)

11.4.5 Bayer Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Medical Nuclide Products Introduction

11.5.4 Eli Lilly Revenue in Medical Nuclide Products Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 Bracco Imaging

11.6.1 Bracco Imaging Company Details

11.6.2 Bracco Imaging Business Overview

11.6.3 Bracco Imaging Medical Nuclide Products Introduction

11.6.4 Bracco Imaging Revenue in Medical Nuclide Products Business (2020-2025)

11.6.5 Bracco Imaging Recent Development

11.7 Curium Pharma

11.7.1 Curium Pharma Company Details

11.7.2 Curium Pharma Business Overview

11.7.3 Curium Pharma Medical Nuclide Products Introduction

11.7.4 Curium Pharma Revenue in Medical Nuclide Products Business (2020-2025)

11.7.5 Curium Pharma Recent Development

11.8 Jubilant Pharmova

11.8.1 Jubilant Pharmova Company Details

11.8.2 Jubilant Pharmova Business Overview

11.8.3 Jubilant Pharmova Medical Nuclide Products Introduction

11.8.4 Jubilant Pharmova Revenue in Medical Nuclide Products Business (2020-2025)

11.8.5 Jubilant Pharmova Recent Development

11.9 Aurobindo Pharma

11.9.1 Aurobindo Pharma Company Details

11.9.2 Aurobindo Pharma Business Overview

11.9.3 Aurobindo Pharma Medical Nuclide Products Introduction

11.9.4 Aurobindo Pharma Revenue in Medical Nuclide Products Business (2020-2025)

11.9.5 Aurobindo Pharma Recent Development

11.10 Novartis

11.10.1 Novartis Company Details

11.10.2 Novartis Business Overview

11.10.3 Novartis Medical Nuclide Products Introduction

11.10.4 Novartis Revenue in Medical Nuclide Products Business (2020-2025)

11.10.5 Novartis Recent Development

11.11 Siemens

11.11.1 Siemens Company Details

11.11.2 Siemens Business Overview

11.11.3 Siemens Medical Nuclide Products Introduction

11.11.4 Siemens Revenue in Medical Nuclide Products Business (2020-2025)

11.11.5 Siemens Recent Development

11.12 NTP Radioisotopes

11.12.1 NTP Radioisotopes Company Details

11.12.2 NTP Radioisotopes Business Overview

11.12.3 NTP Radioisotopes Medical Nuclide Products Introduction

11.12.4 NTP Radioisotopes Revenue in Medical Nuclide Products Business (2020-2025)

11.12.5 NTP Radioisotopes Recent Development

11.13 ANSTO

11.13.1 ANSTO Company Details

11.13.2 ANSTO Business Overview

11.13.3 ANSTO Medical Nuclide Products Introduction

11.13.4 ANSTO Revenue in Medical Nuclide Products Business (2020-2025)

11.13.5 ANSTO Recent Development

11.14 Polatom

11.14.1 Polatom Company Details

11.14.2 Polatom Business Overview

11.14.3 Polatom Medical Nuclide Products Introduction

11.14.4 Polatom Revenue in Medical Nuclide Products Business (2020-2025)

11.14.5 Polatom Recent Development

11.15 China Isotope & Radiation

11.15.1 China Isotope & Radiation Company Details

11.15.2 China Isotope & Radiation Business Overview

11.15.3 China Isotope & Radiation Medical Nuclide Products Introduction

11.15.4 China Isotope & Radiation Revenue in Medical Nuclide Products Business (2020-2025)

11.15.5 China Isotope & Radiation Recent Development

11.16 Yantai Dongcheng Pharmaceutical

11.16.1 Yantai Dongcheng Pharmaceutical Company Details

11.16.2 Yantai Dongcheng Pharmaceutical Business Overview

11.16.3 Yantai Dongcheng Pharmaceutical Medical Nuclide Products Introduction

11.16.4 Yantai Dongcheng Pharmaceutical Revenue in Medical Nuclide Products Business (2020-2025)

11.16.5 Yantai Dongcheng Pharmaceutical Recent Development

11.17 Saide Biotechnology

11.17.1 Saide Biotechnology Company Details

11.17.2 Saide Biotechnology Business Overview

11.17.3 Saide Biotechnology Medical Nuclide Products Introduction

11.17.4 Saide Biotechnology Revenue in Medical Nuclide Products Business (2020-2025)

11.17.5 Saide Biotechnology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

China Isotope & Radiation

Lantheus Medical Imaging

Jubilant Pharmova

Novartis

Yantai Dongcheng Pharmaceutical

Saide Biotechnology

List of Tables

Table 1. Global Medical Nuclide Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Technetium-99m

Table 3. Key Players of Fluorine-18

Table 4. Key Players of Gallium-68

Table 5. Key Players of Iodine-123

Table 6. Key Players of Indium-111

Table 7. Key Players of Copper-64

Table 8. Key Players of Xenon-133

Table 9. Global Medical Nuclide Products Market Size Growth Rate by Product (US$ Million): 2020 VS 2024 VS 2031

Table 10. Key Players of Therapeutic Nuclear Medicine

Table 11. Key Players of Diagnostic Nuclear Medicine

Table 12. Global Medical Nuclide Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 13. Global Medical Nuclide Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 14. Global Medical Nuclide Products Market Size by Region (2020-2025) & (US$ Million)

Table 15. Global Medical Nuclide Products Market Share by Region (2020-2025)

Table 16. Global Medical Nuclide Products Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 17. Global Medical Nuclide Products Market Share by Region (2026-2031)

Table 18. Medical Nuclide Products Market Trends

Table 19. Medical Nuclide Products Market Drivers

Table 20. Medical Nuclide Products Market Challenges

Table 21. Medical Nuclide Products Market Restraints

Table 22. Global Medical Nuclide Products Revenue by Players (2020-2025) & (US$ Million)

Table 23. Global Medical Nuclide Products Market Share by Players (2020-2025)

Table 24. Global Top Medical Nuclide Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Nuclide Products as of 2024)

Table 25. Ranking of Global Top Medical Nuclide Products Companies by Revenue (US$ Million) in 2024

Table 26. Global 5 Largest Players Market Share by Medical Nuclide Products Revenue (CR5 and HHI) & (2020-2025)

Table 27. Global Key Players of Medical Nuclide Products, Headquarters and Area Served

Table 28. Global Key Players of Medical Nuclide Products, Product and Application

Table 29. Global Key Players of Medical Nuclide Products, Date of Enter into This Industry

Table 30. Mergers & Acquisitions, Expansion Plans

Table 31. Global Medical Nuclide Products Market Size by Type (2020-2025) & (US$ Million)

Table 32. Global Medical Nuclide Products Revenue Market Share by Type (2020-2025)

Table 33. Global Medical Nuclide Products Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 34. Global Medical Nuclide Products Revenue Market Share by Type (2026-2031)

Table 35. Global Medical Nuclide Products Market Size by Application (2020-2025) & (US$ Million)

Table 36. Global Medical Nuclide Products Revenue Market Share by Application (2020-2025)

Table 37. Global Medical Nuclide Products Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 38. Global Medical Nuclide Products Revenue Market Share by Application (2026-2031)

Table 39. North America Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. North America Medical Nuclide Products Market Size by Country (2020-2025) & (US$ Million)

Table 41. North America Medical Nuclide Products Market Size by Country (2026-2031) & (US$ Million)

Table 42. Europe Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Europe Medical Nuclide Products Market Size by Country (2020-2025) & (US$ Million)

Table 44. Europe Medical Nuclide Products Market Size by Country (2026-2031) & (US$ Million)

Table 45. Asia-Pacific Medical Nuclide Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 46. Asia-Pacific Medical Nuclide Products Market Size by Region (2020-2025) & (US$ Million)

Table 47. Asia-Pacific Medical Nuclide Products Market Size by Region (2026-2031) & (US$ Million)

Table 48. Latin America Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Latin America Medical Nuclide Products Market Size by Country (2020-2025) & (US$ Million)

Table 50. Latin America Medical Nuclide Products Market Size by Country (2026-2031) & (US$ Million)

Table 51. Middle East & Africa Medical Nuclide Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 52. Middle East & Africa Medical Nuclide Products Market Size by Country (2020-2025) & (US$ Million)

Table 53. Middle East & Africa Medical Nuclide Products Market Size by Country (2026-2031) & (US$ Million)

Table 54. Cardinal Health Company Details

Table 55. Cardinal Health Business Overview

Table 56. Cardinal Health Medical Nuclide Products Product

Table 57. Cardinal Health Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 58. Cardinal Health Recent Development

Table 59. GE Healthcare Company Details

Table 60. GE Healthcare Business Overview

Table 61. GE Healthcare Medical Nuclide Products Product

Table 62. GE Healthcare Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 63. GE Healthcare Recent Development

Table 64. Lantheus Medical Imaging Company Details

Table 65. Lantheus Medical Imaging Business Overview

Table 66. Lantheus Medical Imaging Medical Nuclide Products Product

Table 67. Lantheus Medical Imaging Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 68. Lantheus Medical Imaging Recent Development

Table 69. Bayer Company Details

Table 70. Bayer Business Overview

Table 71. Bayer Medical Nuclide Products Product

Table 72. Bayer Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 73. Bayer Recent Development

Table 74. Eli Lilly Company Details

Table 75. Eli Lilly Business Overview

Table 76. Eli Lilly Medical Nuclide Products Product

Table 77. Eli Lilly Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 78. Eli Lilly Recent Development

Table 79. Bracco Imaging Company Details

Table 80. Bracco Imaging Business Overview

Table 81. Bracco Imaging Medical Nuclide Products Product

Table 82. Bracco Imaging Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 83. Bracco Imaging Recent Development

Table 84. Curium Pharma Company Details

Table 85. Curium Pharma Business Overview

Table 86. Curium Pharma Medical Nuclide Products Product

Table 87. Curium Pharma Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 88. Curium Pharma Recent Development

Table 89. Jubilant Pharmova Company Details

Table 90. Jubilant Pharmova Business Overview

Table 91. Jubilant Pharmova Medical Nuclide Products Product

Table 92. Jubilant Pharmova Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 93. Jubilant Pharmova Recent Development

Table 94. Aurobindo Pharma Company Details

Table 95. Aurobindo Pharma Business Overview

Table 96. Aurobindo Pharma Medical Nuclide Products Product

Table 97. Aurobindo Pharma Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 98. Aurobindo Pharma Recent Development

Table 99. Novartis Company Details

Table 100. Novartis Business Overview

Table 101. Novartis Medical Nuclide Products Product

Table 102. Novartis Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 103. Novartis Recent Development

Table 104. Siemens Company Details

Table 105. Siemens Business Overview

Table 106. Siemens Medical Nuclide Products Product

Table 107. Siemens Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 108. Siemens Recent Development

Table 109. NTP Radioisotopes Company Details

Table 110. NTP Radioisotopes Business Overview

Table 111. NTP Radioisotopes Medical Nuclide Products Product

Table 112. NTP Radioisotopes Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 113. NTP Radioisotopes Recent Development

Table 114. ANSTO Company Details

Table 115. ANSTO Business Overview

Table 116. ANSTO Medical Nuclide Products Product

Table 117. ANSTO Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 118. ANSTO Recent Development

Table 119. Polatom Company Details

Table 120. Polatom Business Overview

Table 121. Polatom Medical Nuclide Products Product

Table 122. Polatom Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 123. Polatom Recent Development

Table 124. China Isotope & Radiation Company Details

Table 125. China Isotope & Radiation Business Overview

Table 126. China Isotope & Radiation Medical Nuclide Products Product

Table 127. China Isotope & Radiation Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 128. China Isotope & Radiation Recent Development

Table 129. Yantai Dongcheng Pharmaceutical Company Details

Table 130. Yantai Dongcheng Pharmaceutical Business Overview

Table 131. Yantai Dongcheng Pharmaceutical Medical Nuclide Products Product

Table 132. Yantai Dongcheng Pharmaceutical Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 133. Yantai Dongcheng Pharmaceutical Recent Development

Table 134. Saide Biotechnology Company Details

Table 135. Saide Biotechnology Business Overview

Table 136. Saide Biotechnology Medical Nuclide Products Product

Table 137. Saide Biotechnology Revenue in Medical Nuclide Products Business (2020-2025) & (US$ Million)

Table 138. Saide Biotechnology Recent Development

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

Table 142. Authors List of This Report

List of Figures

Figure 1. Medical Nuclide Products Picture

Figure 2. Global Medical Nuclide Products Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Medical Nuclide Products Market Share by Type: 2024 VS 2031

Figure 4. Technetium-99m Features

Figure 5. Fluorine-18 Features

Figure 6. Gallium-68 Features

Figure 7. Iodine-123 Features

Figure 8. Indium-111 Features

Figure 9. Copper-64 Features

Figure 10. Xenon-133 Features

Figure 11. Iodine-131 Features

Figure 12. Yttrium-90 Features

Figure 13. Global Medical Nuclide Products Market Size Comparison by Product (2020-2031) & (US$ Million)

Figure 14. Therapeutic Nuclear Medicine Features

Figure 15. Diagnostic Nuclear Medicine Features

Figure 16. Global Medical Nuclide Products Market Size by Application (2020-2031) & (US$ Million)

Figure 17. Global Medical Nuclide Products Market Share by Application: 2024 VS 2031

Figure 18. Cancer Case Studies

Figure 19. Cardiovascular Disease Case Studies

Figure 20. Bone and Joint Disease Case Studies

Figure 21. Other Case Studies

Figure 22. Medical Nuclide Products Report Years Considered

Figure 23. Global Medical Nuclide Products Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 24. Global Medical Nuclide Products Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 25. Global Medical Nuclide Products Market Share by Region: 2024 VS 2031

Figure 26. Global Medical Nuclide Products Market Share by Players in 2024

Figure 27. Global Medical Nuclide Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Medical Nuclide Products Revenue in 2024

Figure 29. North America Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. North America Medical Nuclide Products Market Share by Country (2020-2031)

Figure 31. United States Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Canada Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Europe Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Medical Nuclide Products Market Share by Country (2020-2031)

Figure 35. Germany Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. France Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. U.K. Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Italy Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Russia Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Ireland Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Asia-Pacific Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Medical Nuclide Products Market Share by Region (2020-2031)

Figure 43. China Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Japan Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. South Korea Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. India Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Australia & New Zealand Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Latin America Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Medical Nuclide Products Market Share by Country (2020-2031)

Figure 51. Mexico Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Brazil Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Middle East & Africa Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Medical Nuclide Products Market Share by Country (2020-2031)

Figure 55. Israel Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. UAE Medical Nuclide Products Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. Cardinal Health Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 59. GE Healthcare Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 60. Lantheus Medical Imaging Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 61. Bayer Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 62. Eli Lilly Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 63. Bracco Imaging Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 64. Curium Pharma Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 65. Jubilant Pharmova Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 66. Aurobindo Pharma Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 67. Novartis Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 68. Siemens Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 69. NTP Radioisotopes Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 70. ANSTO Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 71. Polatom Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 72. China Isotope & Radiation Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 73. Yantai Dongcheng Pharmaceutical Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 74. Saide Biotechnology Revenue Growth Rate in Medical Nuclide Products Business (2020-2025)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions